Advanced PRAME Positive Cancers: IMC-P115C Treatment

We are testing a new treatment called IMC-P115C for patients with advanced cancers that are PRAME positive. This study aims to evaluate the safety and appropriate dosage of this new therapy.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre Leon Berard
Medical Oncology
Meyzieu, France
Institut Universitaire Du Cancer Toulouse-Oncopole
Unité de Recherche Clinique
Portet-sur-Garonne, France
Institut Gustave Roussy
Drug Development Department (DITEP)
Villejuif, France

Sponsor: Immunocore Limited
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.